ACE2 and COVID-19: Yet the presence of the soluble and active isoform of ACE2 may be beneficial in COVID-19 patients since soluble ACE2 may compete with the membrane enzyme, limiting its role as a SARS-CoV-2 receptor, and decreasing the Ang II plasma levels (Khodarahmi et al., 2021).